Altered large-scale organization of shape processing in visual agnosia.


Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 11 2019
revised: 29 02 2020
accepted: 04 05 2020
pubmed: 24 6 2020
medline: 22 6 2021
entrez: 24 6 2020
Statut: ppublish

Résumé

Recent findings suggest that both dorsal and ventral visual pathways process shape information. Nevertheless, a lesion to the ventral pathway alone can result in visual agnosia, an impairment in shape perception. Here, we explored the neural basis of shape processing in a patient with visual agnosia following a circumscribed right hemisphere ventral lesion and evaluated longitudinal changes in the neural profile of shape representations. The results revealed a reduction of shape sensitivity slopes along the patient's right ventral pathway and a similar reduction in the contralesional left ventral pathway. Remarkably, posterior parts of the dorsal pathway bilaterally also evinced a reduction in shape sensitivity. These findings were similar over a two-year interval, revealing that a focal cortical lesion can lead to persistent large-scale alterations of the two visual pathways. These alterations are consistent with the view that a distributed network of regions contributes to shape perception.

Identifiants

pubmed: 32574843
pii: S0010-9452(20)30198-2
doi: 10.1016/j.cortex.2020.05.009
pmc: PMC9972005
mid: NIHMS1874550
pii:
doi:

Types de publication

Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-435

Subventions

Organisme : NEI NIH HHS
ID : R01 EY026701
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027018
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY023067
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing interests.

Références

Nature. 1991 Jan 10;349(6305):154-6
pubmed: 1986306
Cortex. 2018 Jan;98:8-27
pubmed: 27890325
Neuropsychologia. 2010 May;48(6):1828-41
pubmed: 20227431
J Neurosci. 2016 Jan 13;36(2):432-44
pubmed: 26758835
Cereb Cortex. 2019 Jul 5;29(7):3168-3181
pubmed: 30169596
Exp Brain Res. 2003 Nov;153(2):180-9
pubmed: 12961051
Nat Neurosci. 2008 Feb;11(2):224-31
pubmed: 18193041
Cereb Cortex. 2001 Apr;11(4):287-97
pubmed: 11278192
J Exp Psychol Hum Percept Perform. 2003 Feb;29(1):19-42
pubmed: 12669745
Cereb Cortex. 2014 Apr;24(4):1102-18
pubmed: 23250954
Trends Cogn Sci. 2016 Oct;20(10):773-784
pubmed: 27615805
Brain. 1999 Mar;122 ( Pt 3):537-59
pubmed: 10094261
Neuron. 2011 Jul 14;71(1):49-60
pubmed: 21745637
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):E5214-23
pubmed: 25404310
Brain. 2014 Sep;137(Pt 9):2408-22
pubmed: 24871646
Q J Exp Psychol A. 1984 Aug;36(3):385-415
pubmed: 6533691
Brain Struct Funct. 2018 Jul;223(6):2589-2607
pubmed: 29536173
Nat Commun. 2016 Jul 18;7:12141
pubmed: 27424918
Cortex. 1979 Sep;15(3):403-19
pubmed: 540512
Curr Opin Neurobiol. 2015 Aug;33:141-9
pubmed: 25876179
Trends Cogn Sci. 2013 May;17(5):210-9
pubmed: 23608364
Brain. 2013 Sep;136(Pt 9):2784-98
pubmed: 23983030
Open Mind (Camb). 2020 Aug;4:40-56
pubmed: 33225195
J Cogn Neurosci. 2019 Jun;31(6):821-836
pubmed: 30883289
Cogn Neuropsychol. 2003 Oct 1;20(7):641-71
pubmed: 20957588
J Nerv Ment Dis. 1950 Jan;111(1):41-51
pubmed: 15402617
Cereb Cortex. 2017 Jan 1;27(1):422-434
pubmed: 26483400
J Cogn Neurosci. 2015 May;27(5):1029-43
pubmed: 25390203
Cereb Cortex. 2019 May 1;29(5):2034-2050
pubmed: 29659730
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8135-9
pubmed: 7667258
Conscious Cogn. 2018 Sep;64:106-120
pubmed: 29779844
Cortex. 1993 Sep;29(3):529-42
pubmed: 8258290
Elife. 2017 Aug 21;6:
pubmed: 28825896
Cortex. 2018 Jan;98:34-48
pubmed: 28431740
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):E361-70
pubmed: 25583504
PLoS Biol. 2016 Apr 15;14(4):e1002445
pubmed: 27082854
J Cogn Neurosci. 2019 Oct;31(10):1589-1597
pubmed: 31180266
Cortex. 1985 Mar;21(1):121-34
pubmed: 3987306
Neuroreport. 2001 Jun 13;12(8):1581-7
pubmed: 11409720
Magn Reson Med. 1995 Oct;34(4):537-41
pubmed: 8524021
Neurocase. 2002;8(6):466-79
pubmed: 12529455
Elife. 2017 Oct 05;6:
pubmed: 28980938
J Cogn Neurosci. 2018 Jul;30(7):1047-1058
pubmed: 29561234
Brain. 1987 Dec;110 ( Pt 6):1431-62
pubmed: 3427396
J Cogn Neurosci. 2013 Jun;25(6):862-71
pubmed: 23410033
Hum Brain Mapp. 1998;6(4):316-28
pubmed: 9704268
Neuropsychology. 2005 May;19(3):318-31
pubmed: 15910118
J Cogn Neurosci. 2001 May 15;13(4):419-29
pubmed: 11388916
J Nucl Med. 1998 Dec;39(12):2044-7
pubmed: 9867139
Brain. 1991 Apr;114 ( Pt 2):789-800
pubmed: 2043949
Nat Neurosci. 2009 Jan;12(1):29-31
pubmed: 19029889

Auteurs

Erez Freud (E)

Department of Psychology and Centre for Vision Research, York University, Toronto, ON, Canada. Electronic address: efreud@yorku.ca.

Marlene Behrmann (M)

Department of Psychology and the Carnegie Mellon Neuroscience Institute, Carnegie Mellon University, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH